Skip to content

AD PHARMA: what changed

BE 0736.833.279NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€88,132
2024 · €28,775+€59,358
Equity
€118,742
2024 · €30,609+€88,132
Cash
€41,413
2024 · €37,282+€4,131
Balance sheet total
€1.4m
2024 · €259,294+€1.1m

Largest movements

2024 to 2025
Assets
  • Financial fixed assets +€1.1m

    up €1.1m (+646%), from €164,054 to €1.2m

  • Receivables within one year +€55,210

    up €55,210 (+456%), from €12,100 to €67,310

    of which Other amounts receivable: +€67,264

Equity and liabilities
  • Debts after one year +€930,039

    up €930,039 (+917%), from €101,399 to €1.0m

  • Profit (loss) carried forward +€88,132

    up €88,132 (+14,469%), from €609 to €88,742

  • Current portion of long-term debt +€75,902

    up €75,902 (+302%), from €25,156 to €101,059

  • Tax, wage and social debts +€23,768

    up €23,768 (+306%), from €7,755 to €31,522

Income statement
  • Gross operating margin +€100,541

    up €100,541 (+214%), from €46,957 to €147,498

  • Financial charges +€25,762

    up €25,762 (+866%), from €2,975 to €28,737

  • Taxes +€16,843

    up €16,843 (+196%), from €8,598 to €25,440

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €28,775
Gross operating margin +€100,541
Depreciation +€1,360
Other operating charges -€2
Financial income +€64
Financial charges -€25,762
Taxes -€16,843
Result 2025 €88,132
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€58,324
Investment -€1.1m
Financing +€1.0m
Cash 2024 €37,282
Net result for the year +€88,132
Depreciation +€5,668
Receivables within one year -€55,210
Smaller working-capital items -€751
Trade debts -€3,283
Tax, wage and social debts +€23,768
Investment in fixed assets (net) -€1.1m
Debts after one year +€930,039
Current portion of long-term debt +€75,902
Cash 2025 €41,413
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €259,294 €1,372,911 +€1.1m +429%
Fixed assets 21/28 €169,722 €1,224,188 +€1.1m +621%
Tangible fixed assets 22/27 €5,668 - -€5,668
Furniture and vehicles 24 €5,668 - -€5,668
Financial fixed assets 28 €164,054 €1,224,188 +€1.1m +646%
Current assets 29/58 €89,572 €148,723 +€59,151 +66.0%
Amounts receivable within one year 40/41 €12,100 €67,310 +€55,210 +456%
Trade receivables 40 €12,100 €46 -€12,054 -99.6%
Other amounts receivable 41 - €67,264 +€67,264
Current investments 50/53 €40,000 €40,000 = 0.0%
Cash at bank and in hand 54/58 €37,282 €41,413 +€4,131 +11.1%
Deferred charges and accrued income 490/1 €190 - -€190
Total equity and liabilities 10/49 €259,294 €1,372,911 +€1.1m +429%
Equity 10/15 €30,609 €118,742 +€88,132 +288%
Contributions 10/11 €30,000 €30,000 = 0.0%
Profit (loss) carried forward 14 €609 €88,742 +€88,132 +14,469%
Amounts payable 17/49 €228,685 €1,254,170 +€1.0m +448%
Amounts payable after more than one year 17 €101,399 €1,031,438 +€930,039 +917%
Financial debts 170/4 €101,399 €1,031,438 +€930,039 +917%
Amounts payable within one year 42/48 €127,286 €222,732 +€95,446 +75.0%
Current portion of amounts payable after more than one year 42 €25,156 €101,059 +€75,902 +302%
Trade debts 44 €4,011 €728 -€3,283 -81.9%
Suppliers 440/4 €4,011 €728 -€3,283 -81.9%
Taxes, remuneration and social security 45 €7,755 €31,522 +€23,768 +306%
Taxes 450/3 €7,755 €31,522 +€23,768 +306%
Other amounts payable 47/48 €90,364 €89,423 -€941 -1.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,028 €5,668 -€1,360 -19.3%
Other operating charges 640/8 - €2 +€2
Gross operating margin 9900 €46,957 €147,498 +€100,541 +214%
Operating profit (loss) 9901 €39,929 €141,828 +€101,899 +255%
Financial income 75/76B €418 €481 +€64 +15.2%
Recurring financial income 75 €418 €481 +€64 +15.2%
Financial charges 65/66B €2,975 €28,737 +€25,762 +866%
Recurring financial charges 65 €2,975 €28,737 +€25,762 +866%
Profit (loss) for the period before taxes 9903 €37,372 €113,572 +€76,200 +204%
Income taxes 67/77 €8,598 €25,440 +€16,843 +196%
Profit (loss) for the period 9904 €28,775 €88,132 +€59,358 +206%
Profit (loss) for the period to be appropriated 9905 €28,775 €88,132 +€59,358 +206%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€240,606 to €313,101

Midpoint €270,812 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €118,742
Capitalised earnings €362,471 to €507,460
Indication €240,606 to €313,101

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€118,742
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€118,742

Capitalised earnings

net result for the year (9904)
2025
€88,132
2024
€28,775
2023
€35,332
2022
€62,439
2021
-€12,117
Average result
€50,746
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€362,471 / €422,883 / €507,460

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.